VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-09-30

AUTHORS

G Thurston, J Kitajewski

ABSTRACT

Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis. More... »

PAGES

1204-1209

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484

DOI

http://dx.doi.org/10.1038/sj.bjc.6604484

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048175725

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18827808


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intracellular Signaling Peptides and Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.418961.3", 
          "name": [
            "Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thurston", 
        "givenName": "G", 
        "id": "sg:person.01154473176.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154473176.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.21729.3f", 
          "name": [
            "Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kitajewski", 
        "givenName": "J", 
        "id": "sg:person.01102727732.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102727732.79"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature05355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037678066", 
          "https://doi.org/10.1038/nature05355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042233486", 
          "https://doi.org/10.1038/nrc2130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009360999", 
          "https://doi.org/10.1038/nature05571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045720229", 
          "https://doi.org/10.1038/nature05577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35102599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009535704", 
          "https://doi.org/10.1038/35102599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034553835", 
          "https://doi.org/10.1038/nature05313"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-09-30", 
    "datePublishedReg": "2008-09-30", 
    "description": "Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6604484", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2536843", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "keywords": [
      "tumor angiogenesis", 
      "VEGF pathway", 
      "course of treatment", 
      "most current therapies", 
      "ligand Delta-like 4", 
      "current therapies", 
      "Delta-like 4", 
      "VEGF blocker", 
      "antitumour therapy", 
      "angiogenesis", 
      "new targets", 
      "therapy", 
      "tumors", 
      "important target", 
      "VEGF", 
      "pathway", 
      "Delta-Notch pathway", 
      "blockers", 
      "target", 
      "treatment", 
      "activation", 
      "Delta-Notch", 
      "cell fate decisions", 
      "stimuli", 
      "fate decisions", 
      "course", 
      "need", 
      "features", 
      "important features", 
      "picture", 
      "decisions", 
      "upstream", 
      "way", 
      "manifold ways"
    ], 
    "name": "VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis", 
    "pagination": "1204-1209", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048175725"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604484"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18827808"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604484", 
      "https://app.dimensions.ai/details/publication/pub.1048175725"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_461.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6604484"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'


 

This table displays all metadata directly associated to this object as RDF triples.

163 TRIPLES      21 PREDICATES      73 URIs      59 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604484 schema:about N2643759c53f64d3eb848c6126168d623
2 N2731aad7396947a99fcd2fcf357a7ab3
3 N58ca7925fa4148608062b400490f768f
4 N6d65786db9e640b384954c8e747342a4
5 N9b33b84d0e9f449684f917782898af25
6 Nb628f4e92993402991212efaf0a914b2
7 Nbf1dfa0428274055a10b44dcc000dca5
8 Nf7faaa7480954ed3ac363a014861f052
9 anzsrc-for:11
10 anzsrc-for:1112
11 schema:author Nc8c1340d4a544bcfa6ef9469f0b54587
12 schema:citation sg:pub.10.1038/35102599
13 sg:pub.10.1038/nature05313
14 sg:pub.10.1038/nature05355
15 sg:pub.10.1038/nature05571
16 sg:pub.10.1038/nature05577
17 sg:pub.10.1038/nrc2130
18 schema:datePublished 2008-09-30
19 schema:datePublishedReg 2008-09-30
20 schema:description Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis.
21 schema:genre article
22 schema:isAccessibleForFree true
23 schema:isPartOf N82d2b6d04d6a4390b45f669df2738b2e
24 Nb6839ab21b1f4f5690618f13e632f417
25 sg:journal.1017082
26 schema:keywords Delta-Notch
27 Delta-Notch pathway
28 Delta-like 4
29 VEGF
30 VEGF blocker
31 VEGF pathway
32 activation
33 angiogenesis
34 antitumour therapy
35 blockers
36 cell fate decisions
37 course
38 course of treatment
39 current therapies
40 decisions
41 fate decisions
42 features
43 important features
44 important target
45 ligand Delta-like 4
46 manifold ways
47 most current therapies
48 need
49 new targets
50 pathway
51 picture
52 stimuli
53 target
54 therapy
55 treatment
56 tumor angiogenesis
57 tumors
58 upstream
59 way
60 schema:name VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
61 schema:pagination 1204-1209
62 schema:productId N16134a1d89a845958bf99ae1aa5cad5a
63 N468accc9f1274f3f8b2768f1e2be310e
64 Na76356aeff3940789a8b990a3068f959
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048175725
66 https://doi.org/10.1038/sj.bjc.6604484
67 schema:sdDatePublished 2022-09-02T15:52
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N981557b7306b443d88eeaf5b2d1926f3
70 schema:url https://doi.org/10.1038/sj.bjc.6604484
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N144a6706b4c24959b10b28e212c8aabc rdf:first sg:person.01102727732.79
75 rdf:rest rdf:nil
76 N16134a1d89a845958bf99ae1aa5cad5a schema:name doi
77 schema:value 10.1038/sj.bjc.6604484
78 rdf:type schema:PropertyValue
79 N2643759c53f64d3eb848c6126168d623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Animals
81 rdf:type schema:DefinedTerm
82 N2731aad7396947a99fcd2fcf357a7ab3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Neovascularization, Pathologic
84 rdf:type schema:DefinedTerm
85 N468accc9f1274f3f8b2768f1e2be310e schema:name pubmed_id
86 schema:value 18827808
87 rdf:type schema:PropertyValue
88 N58ca7925fa4148608062b400490f768f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Intracellular Signaling Peptides and Proteins
90 rdf:type schema:DefinedTerm
91 N6d65786db9e640b384954c8e747342a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Humans
93 rdf:type schema:DefinedTerm
94 N82d2b6d04d6a4390b45f669df2738b2e schema:issueNumber 8
95 rdf:type schema:PublicationIssue
96 N981557b7306b443d88eeaf5b2d1926f3 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N9b33b84d0e9f449684f917782898af25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Vascular Endothelial Growth Factor A
100 rdf:type schema:DefinedTerm
101 Na76356aeff3940789a8b990a3068f959 schema:name dimensions_id
102 schema:value pub.1048175725
103 rdf:type schema:PropertyValue
104 Nb628f4e92993402991212efaf0a914b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Membrane Proteins
106 rdf:type schema:DefinedTerm
107 Nb6839ab21b1f4f5690618f13e632f417 schema:volumeNumber 99
108 rdf:type schema:PublicationVolume
109 Nbf1dfa0428274055a10b44dcc000dca5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Signal Transduction
111 rdf:type schema:DefinedTerm
112 Nc8c1340d4a544bcfa6ef9469f0b54587 rdf:first sg:person.01154473176.34
113 rdf:rest N144a6706b4c24959b10b28e212c8aabc
114 Nf7faaa7480954ed3ac363a014861f052 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Neoplasms
116 rdf:type schema:DefinedTerm
117 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
118 schema:name Medical and Health Sciences
119 rdf:type schema:DefinedTerm
120 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
121 schema:name Oncology and Carcinogenesis
122 rdf:type schema:DefinedTerm
123 sg:grant.2536843 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6604484
124 rdf:type schema:MonetaryGrant
125 sg:journal.1017082 schema:issn 0007-0920
126 1532-1827
127 schema:name British Journal of Cancer
128 schema:publisher Springer Nature
129 rdf:type schema:Periodical
130 sg:person.01102727732.79 schema:affiliation grid-institutes:grid.21729.3f
131 schema:familyName Kitajewski
132 schema:givenName J
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102727732.79
134 rdf:type schema:Person
135 sg:person.01154473176.34 schema:affiliation grid-institutes:grid.418961.3
136 schema:familyName Thurston
137 schema:givenName G
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154473176.34
139 rdf:type schema:Person
140 sg:pub.10.1038/35102599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009535704
141 https://doi.org/10.1038/35102599
142 rdf:type schema:CreativeWork
143 sg:pub.10.1038/nature05313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034553835
144 https://doi.org/10.1038/nature05313
145 rdf:type schema:CreativeWork
146 sg:pub.10.1038/nature05355 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037678066
147 https://doi.org/10.1038/nature05355
148 rdf:type schema:CreativeWork
149 sg:pub.10.1038/nature05571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009360999
150 https://doi.org/10.1038/nature05571
151 rdf:type schema:CreativeWork
152 sg:pub.10.1038/nature05577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045720229
153 https://doi.org/10.1038/nature05577
154 rdf:type schema:CreativeWork
155 sg:pub.10.1038/nrc2130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042233486
156 https://doi.org/10.1038/nrc2130
157 rdf:type schema:CreativeWork
158 grid-institutes:grid.21729.3f schema:alternateName Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA
159 schema:name Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA
160 rdf:type schema:Organization
161 grid-institutes:grid.418961.3 schema:alternateName Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA
162 schema:name Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA
163 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...